Coronary stenting in cardiac allograft vasculopathy
Suresh P. Jain, MDa,
Stephen R. Ramee, MD, FACCa,
Christopher J. White, MD, FACCa,
Mandeep R. Mehra, MD, FACCa,
Hector O. Ventura, MD, FACCa,
Shuyang Zhang, MDa,
J. Stephen Jenkins, MD, FACCa and
Tyrone J. Collins, MD, FACCa
a Department of Cardiology, Ochsner Clinic, New Orleans, Louisiana, USA
View larger version (29K):
[in a new window]
|
Figure 1 Lesion location of the stented arteries. LM = left main coronary artery (n = 1); LAD = left anterior descending artery (n = 8); diagonal artery (n = 3); LCx = left circumflex artery (n = 2); RCA = right coronary artery (n = 5).
|
|
View larger version (105K):
[in a new window]
|
Figure 2 Upper panel demonstrates stenting of a mid left anterior descending artery (LAD) lesion in a patient who is 4 years posttransplant; (A) Baseline angiogram showing a severe stenosis (arrow) in the midLAD region; (B) Poststent angiographic frame showing no residual stenosis (arrow); (C) Angiographic follow-up (F/U) at 6 months shows a patent lumen (arrow) without any restenosis. Lower panel demonstrates stenting of a left main coronary lesion in a patient who presented with unstable angina 6 years after cardiac transplant; (A) Baseline angiogram showing a severe stenosis in the body of the left main coronary artery; (B) After placement of a 4-mm stent; (C and D) Follow-up angiography at 6 months and 2 years, respectively, showing minimal luminal narrowing within the stent.
|
|
View larger version (12K):
[in a new window]
|
Figure 3 Cumulative frequency of minimal luminal diameter at baseline, immediately after stent implantation and at follow-up.
|
|
|
